Stars 0 No Patient
Satisfaction Reviews
Why not?
SHOW ALL RATINGS+
Specialty:

Surgery

Secondary Specialty:

Pediatric Surgery
Transplant Surgery
Pediatric Transplant Surgery

Education:

MD, University of Sydney Sydney, Australia

Residency:

Concord General Hospital
NSW,
Westmead Hospital
Sydney, Australia
Concord General Hospital
NSW,
Westmead Hospital
Sydney, Australia

Fellowships:

University of Pittsburgh Medical School
Pittsburgh, PA
Royal Prince Alfred Hospital
New South Wales,
New Children's Hospital
New South Wales,
Royal Children's Hospital - Brisbane
Queensland,
University of Pittsburgh School of Medicine
Pittsburgh, PA
Royal Prince Alfred Hospital
New South Wales,
New Children's Hospital
New South Wales,
Royal Children's Hospital - Brisbane
Queensland,

Affiliations:

UPMC Presbyterian
Magee-Womens Hospital of UPMC
Children's Hospital of Pittsburgh of UPMC
UPMC Children's Surgery Centers

Geoffrey James Bond, MD

Doctor

Transplant Director, Pediatric Intestinal Care Center, University of Pittsburgh, Thomas E. Starzl Transplantation Institute
Assistant Professor in Transplant Surgery, University of Pittsburgh, Thomas E. Starzl Transplantation Institute

Locations and Directions

SHOW ALL LOCATIONS+

Biography

Research Interests

  • Intestinal Failure in Children: A Contemporary Retrospective Review by the Pediatric Intestinal Failure Consortium
  • Functional Outcomes in Pediatric Liver Transplantation
  • Normal Humane Subjects for Immune Assay Development
  • Vitamin B6 Status during Restoration of Nutritional Autonomy in Adults Post Intestinal Transplantation
  • Biomarkers in Transplant Recipients
  • Studies on Pediatric Liver Transplantation (SPLIT) a Multi-Center, Prospective Study to Collect Scientific Data on Pediatric Liver Transplantation
  • Biologic Studies of Organ Failure and Transplant
  • Pharmacodynamics, Pharmacogenomics and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus Monotherapy in Pediatric Intestinal Transplantation
  • The Assessment of Voriconazole Pharmacokinetics in Small Bowel Transplant Recipients
  • An Evaluation of the Physiological and Pathological Factors that Affect the Oral Bioavailability of Tacrolimus in Small Bowel Transplant Patients
  • Low Dose Ex-vivo X-Irradiation of the Allograft and Simultaneous Bone Marrow Cell Infusion to Enhance Intestinal/Multivisceral Allograft Survival
  • Ongoing clinical research into intestinal and multivisceral transplantation in adults and children further developing the field and making it more widely applicable throughout the USA and across the world. This has involved constant modifications in patient management, surgical techniques, and in particular immunosuppressive strategies, including comparing previous protocols, irradiation of the intestinal allograft, and the latest tolerogenic strategy.
  • One of two surgeons who performed the initial intestinal transplantation using a new tolerogenic immunosuppressive protocol in Pittsburgh. This tolerogenic protocol attempts to induce tolerance and graft acceptance with the aim of minimizing post transplantation immunosuppression requirements.
  • Contributing to a multicenter international study, assessing the efficacy and utility of a new gut hormone to stimulate growth in TPN dependent short bowel syndrome patients. This may help patients come off TPN and avoid transplantation. In addition, I will be contributing to a multicenter study of mechanisms of adaptation in short bowel syndrome.
  • As both a pediatric surgeon and transplant surgeon and with the experience achieved from the adult intestinal rehabilitation unit, I will become intimately involved in the expansion of a pediatric intestinal failure unit. This will benefit the pediatric intestinal failure population as a whole and offer seamless transitional care to the necessary modalities of treatment.

View Dr. Bond's full list of publications from PubMed.

Biography Summary

Geoff Bond, MD is a surgical co-director of the Intestinal Care and Rehabilitation Center at Children's Hospital of Pittsburgh of UPMC. He contributes to a multicenter study assessing the efficacy and utility of a new gut hormone to stimulate growth in TPN dependent short bowel syndrome patients. This may help patients come off TPN and avoid transplantation.

Dr. Bond’s research focuses on intestinal and multivisceral transplantation in adults and children to further develop the field and make it more widely applicable. This has involved constant modifications in patient management, surgical techniques, and in particular immunosuppressive strategies, including comparing previous protocols, irradiation of the intestinal allograft, and the latest tolerogenic strategy.

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and are displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Total Comments: 0

SHOW ALL COMMENTS+